CDC: Updated Influenza Vaccination Recommendations for 2019-2020
The ACIP has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2019–2020 season.
Vaccines
High-Dose, Quadrivalent Influenza B Vaccine Is safe and Immunogenic
Compared with the standard-dose influenza vaccine, a high-dose quadrivalent inactivated influenza vaccine, GC3114, may provide a more effective influenza vaccine option for the elderly population.
Updated Recommendations for Pediatric Immunization Schedules in the United States
In conjunction with its release of the adult guidelines earlier this year, the ACIP earlier this year has issued an annual update on pediatric immunization schedules.
Factors Linked to Pneumococcal Vaccination Status in Type 2 Diabetes
Patients with diabetes are at higher risk for hospitalization and mortality because of pneumococcal infection; however, uptake of vaccination remains suboptimal.
Efficacy of Quadrivalent Inactivated Influenza Vaccine in Young Children
In children aged 6–35 months, vaccination with 2 doses of IIV4 can protect against influenza and reduces the frequency of severe outcomes.
Effects of Sequential Influenza A Vaccination on Antibody Waning
Postvaccination antibody titers against influenza A similar across successive vaccinations but efficacy wanes with vaccine rates.
New Tuberculosis Vaccine Raises Hope for TB Prevention
A new vaccine candidate may stave off active TB in M tuberculosis-infected adults.
Increased Risk for Acute Respiratory Illness Following Influenza Vaccine in Children
Among children there was an increased risk for acute respiratory illness caused by noninfluenza respiratory pathogens following influenza vaccination compared to unvaccinated children during the same period.
Influenza Vaccination in Pediatric Emergency Departments
Influenza vaccination in the pediatric emergency department setting appears to be a cost-effective strategy.
Temporary MTX Discontinuation Improves Flu Vaccine Immunogenicity in RA
Temporary discontinuation of methotrexate after influenza vaccination is associated with improved immunogenicity of vaccination in RA.
